U.S. opts for 100M more doses of Pfizer-BioNTech COVID-19 vaccine

By The Science Advisory Board staff writers

February 12, 2021 -- The U.S. government has exercised its option for an additional 100 million doses of the Pfizer-BioNTech COVID-19 vaccine

The U.S. government's order brings the total number of doses committed from Pfizer and BioNTech to 300 million or enough to vaccinate 150 million people under the two-dose regimen.

According to the agreement, the U.S. government will pay $1.95 billion for the additional 100 million doses. These doses will be provided for free to eligible U.S. residents as part of the government's commitment for free access to COVID-19 vaccines.

The vaccine doses will continue to be manufactured at Pfizer's Kalamazoo, MI, manufacturing site, according to the firms.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.